KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other Accumulated Expenses (2016 - 2026)

Boston Scientific's Other Accumulated Expenses history spans 18 years, with the latest figure at $875.0 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 5.2% to $875.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $875.0 million, a 5.2% decrease, with the full-year FY2025 number at $795.0 million, down 10.37% from a year prior.
  • Other Accumulated Expenses hit $875.0 million in Q1 2026 for Boston Scientific, up from $795.0 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for BSX hit a ceiling of $1.0 billion in Q1 2022 and a floor of $752.0 million in Q3 2022.
  • Historically, Other Accumulated Expenses has averaged $855.1 million across 5 years, with a median of $862.0 million in 2025.
  • Biggest five-year swings in Other Accumulated Expenses: surged 46.67% in 2022 and later dropped 23.89% in 2023.
  • Tracing BSX's Other Accumulated Expenses over 5 years: stood at $761.0 million in 2022, then increased by 6.96% to $814.0 million in 2023, then rose by 8.97% to $887.0 million in 2024, then decreased by 10.37% to $795.0 million in 2025, then rose by 10.06% to $875.0 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for BSX at $875.0 million in Q1 2026, $795.0 million in Q4 2025, and $862.0 million in Q3 2025.